SCHEMBL2654417

SCHEMBL2654417

CC(C)ON(N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373455 0.71 ADH1B (0.32)
SCHEMBL12534579 0.71
SCHEMBL10642205 0.67
SCHEMBL5547568 0.63
SCHEMBL9509608 0.61
SCHEMBL3728774 0.61
Dimethylformamide SCHEMBL5753147 0.59 TSHR (0.56)
SCHEMBL29261029 0.57
SCHEMBL15195782 0.57
SCHEMBL1556089 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070078168-A1 PYRIDINE CARBOXYLIC ACID DERIVATIVES AS GLUCOKINASE MODULATORS ASTRAZENECA AB (SE) 2007-04-05 US disclosed
CN-1898209-A Pyridinecarboxylic acid derivatives as glucokinase modulators ASTRAZENECA AB (SE) 2007-01-17 CN disclosed
EP-1682509-A1 PYRIDINE CARBOXYLIC ACID DERIVATIVES AS GLUCOKINASE MODULATORS AstraZeneca AB (SE) 2006-07-26 EP disclosed
WO-2005044801-A1 PYRIDINE CARBOXYLIC ACID DERIVATIVES AS GLUCOKINASE MODULATORS ASTRAZENECA AB (SE) 2005-05-19 WO disclosed